Study to Evaluate Real-world Pharmacoeconomics and Resistance Mechanisms of Panitumumab in Metastatic Colorectal Cancer Patients

Clinical trial NCT02135757 · COMPLETED

Trial details

NCT number: NCT02135757
Sponsor: PeriPharm
Status: COMPLETED
Study type: OBSERVATIONAL

Colorectal Cancer Metastatic

Start date: 2014-08-01
Primary completion: 2018-03-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.